Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
June 11, 2021
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells
Giuseppe Faudone, Iris Bischoff-Kont, Lea Rachor, et al.
Angewandte Chemie (International Ed. in English)
|
November 7, 2024
A Photochemical Strategy towards Michael Addition Reactions of Cyclopropenes
Yaseen Hussain, Prasanna R, Claire Empel, et al.
Chemmedchem
|
November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
Simone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of the American Chemical Society
|
June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
Silvia Arifi, Julian A Marschner, Julius Pollinger, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
Jennifer Alisa Amrhein, Lena Marie Berger, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters
Victor Hernandez-Olmos, Jan Heering, Viktoria Planz, et al.
Bioorganic & Medicinal Chemistry
|
September 25, 2019
Structure optimization of a new class of PPARγ antagonists
Victor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Future Medicinal Chemistry
|
May 21, 2013
Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO
Estel la Buscató, Joanna M Wisniewska, Carmen B Rödl, et al.
International Journal of Molecular Sciences
|
November 25, 2020
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19
Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
Jurema Schmidt, Marco Rotter, Tim Weiser, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
June 11, 2021
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells
Giuseppe Faudone, Iris Bischoff-Kont, Lea Rachor, et al.
Angewandte Chemie (International Ed. in English)
|
November 7, 2024
A Photochemical Strategy towards Michael Addition Reactions of Cyclopropenes
Yaseen Hussain, Prasanna R, Claire Empel, et al.
Chemmedchem
|
November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
Simone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of the American Chemical Society
|
June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
Silvia Arifi, Julian A Marschner, Julius Pollinger, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
Jennifer Alisa Amrhein, Lena Marie Berger, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters
Victor Hernandez-Olmos, Jan Heering, Viktoria Planz, et al.
Bioorganic & Medicinal Chemistry
|
September 25, 2019
Structure optimization of a new class of PPARγ antagonists
Victor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Future Medicinal Chemistry
|
May 21, 2013
Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO
Estel la Buscató, Joanna M Wisniewska, Carmen B Rödl, et al.
International Journal of Molecular Sciences
|
November 25, 2020
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19
Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
Jurema Schmidt, Marco Rotter, Tim Weiser, et al.
Page
of 5